Form 4 for FATE FATE THERAPEUTICS INC
Accepted 2022-01-04 00:00:00 ET · period of report 2022-01-03 · accession 0001209191-22-000647 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-01-04 | 2022-01-03 | FATE | TAHL CINDY | GC, Sec | S - Sale+OE | $59.34 | -50.0K | 214.6K | -19% | -$2.97M |
| D | 2022-01-04 | 2022-01-03 | FATE | TAHL CINDY | GC, Sec | M - OptEx | $6.55 | +50.0K | 219.0K | +30% | +$327.5K |
| D | 2022-01-04 | 2022-01-03 | FATE | TAHL CINDY | GC, Sec | M - OptEx | $0.00 | -50.0K | 66.6K | -43% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-01-03 | S | D | 16,900 | $58.84 | 197,679 | D | — | — | (F3) Represents the weighted average sale price of the shares sold ranging from $58.26 to $59.25 per share. |
| 2 | Common | Common Stock | 2022-01-03 | S | D | 861 | $60.31 | 169,006 | D | — | — | (F5) Represents the weighted average sale price of the shares sold ranging from $60.30 to $60.33 per share. |
| 3 | Common | Common Stock | 2022-01-03 | S | D | 27,812 | $59.86 | 169,867 | D | — | — | (F4) Represents the weighted average sale price of the shares sold ranging from $59.30 to $60.29 per share. |
| 4 | Common | Common Stock | 2022-01-03 | M | A | 50,000 | $6.55 | 219,006 | D | — | — | |
| 5 | Common | Common Stock | 2022-01-03 | S | D | 4,427 | $57.76 | 214,579 | D | — | — | (F2) Represents the weighted average sale price of the shares sold ranging from $57.26 to $58.18 to per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each price within the ranges set forth in footnotes 2 through 5. |
| 6 | Derivative | Stock Option (Right to Buy) | 2022-01-03 | M | D | 50,000 | $0.00 | 66,643 | D | $6.55 · — to 2028-01-16 | 50,000 Common Stock | (F6) This option is fully vested. |